肝脏CD4T细胞预测肝细胞癌风险对代谢功能障碍相关的脂肪肝炎患者患者
Emilse Rodriguez1, Peter Simon2, Sabrina Dhooge3
1Hospital Privado Centro Médico de Córdoba S.A., Córdoba, Argentina.
United European gastroenterology journal
|December 12, 2025
概括
肝脏中增加的CD4+T细胞透预测了在患有代谢功能障碍相关的脂肪肝炎 (MASH) 患者中肝细胞癌 (HCC) 的发展. 将免疫细胞数据与临床因素相结合,为高风险MASH患者提供了强大的预测价值.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 代谢功能障碍相关的脂肪肝炎 (MASH) 是导致肝癌的原因之一.
- 了解MASH中的免疫微环境对于预测肝细胞癌 (HCC) 发展至关重要.
研究的目的:
- 在MASH患者的肝活检中表征炎症透物,这些患者患有HCC与对照.
- 为了确定与MASH诱导的HCC进展相关的预测性免疫特征.
主要方法:
- 使用多重免疫组织化学分析MASH患者 (HCC前和对照) 肝脏活检的分析.
- 单细胞RNA-seq用于表征肝脏CD4+T细胞异质性.
- 评估临床参数,包括肝功能测试和血小板计数.
主要成果:
- 与对照组相比,HCC前MASH显示炎症分布发生变化.
- 在HCC前MASH患者中观察到显著更高的CD4+T细胞和CD4+PD1+细胞密度.
- 免疫细胞数据和临床变量的组合实现了高预测性表现 (AUC=0.944) 对于HCC发展.
结论:
- 肝脏CD4+ T细胞透的增加是MASH向HCC进展的关键特征.
- 免疫特征与临床参数相结合,可以有效地识别高风险的MASH患者.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
169
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
169
Liver Regeneration
4.2K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.2K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
200
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
200


